Recently, TG6 variants were found to differ in patients suffering from Parkinson’s disease, with the wildtype protein having a protective effect on cells by decreasing alpha-synuclein levels and enhancing autophagy [28]. This evidence concerns the gene SNCA and Parkinson disease.